$MGRX Mangoceuticals, Inc. Announces TV Air Dates
Post# of 103076
(Total Views: 109)
Posted On: 07/14/2023 7:56:35 AM
$MGRX Mangoceuticals, Inc. Announces TV Air Dates for Interview Featuring CEO Jacob Cohen on Fox Business, Bloomberg TV, and Newsmax TV
July 12 2023 - 10:00AM
GlobeNewswire Inc.
Alert
Print
Share On Facebook
Mangoceuticals, Inc. (NASDAQ:MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing and selling a variety of men’s health and wellness products via a secure telemedicine platform, including its uniquely formulated erectile dysfunction (ED) drug branded “Mango,” is pleased to announce air dates for the first episode of a multi-part TV series on FMW Media’s “New To The Street” business TV show featuring an in-depth interview with Mangoceuticals, Inc.’s CEO, Jacob Cohen.
The interview was filmed at the Nasdaq MarketSite Studio and will air on Fox Business Network, Bloomberg TV (as a sponsored program), and Newsmax TV (through its syndicated and sponsored networks) as follows:
July 22 at 3:30 p.m. ET on Newsmax TV
July 24 at 10:30 p.m. PT on Fox Business
August 5 at 6 p.m. ET on Bloomberg TV
Jane King, the host of New To The Street, sat down with Mr. Cohen to discuss Mangoceuticals’ vision, including how the Company identified its market opportunity and how it plans to execute its business plan in strategic planning terms.
In the interview, Mr. Cohen began by noting that the rise of direct-to-consumer telemedicine as an emerging pathway has attracted tremendous interest and the formation of many new businesses focused on selling health and wellness products through expanding telemedicine platforms.
But that the current product offerings amongst the competition in the market lacked innovation. MangoRx is predicated, in part, on stepping into that equation and introducing something capable of capitalizing on the emergence of direct-to-consumer telemedicine platforms while simultaneously disrupting the Men’s Health and Wellness marketplace. He points out that the Company’s first ED product represents an innovation in both formulation and in its sublingual delivery mechanism. He highlights the Company’s innovative formulation and its approach to marketing in the interview as well.
In addition to containing a proven ED pharma compound, Mango contains other ingredients that promote blood flow and intimacy. But it also offers a more efficient delivery mechanism through rapidly dissolved tablets (RDT) absorbed orally.
Mr. Cohen also discusses the Company’s unique marketing concept involving a high degree of overlap between its consumers and its investors, tying together investor relations and product marketing, which promotes additional ROI gains on capital invested in marketing efforts.
The interview expands to cover the Company’s vision for future expansion into other areas of Men’s Health and Wellness, including areas like hair loss, weight loss, mood, anti-aging, and even hormonal replacement therapies. Cohen concludes by pointing to the Company’s overall mission: to promote men’s performance in all areas and aspects of life.
FMW Media’s "New To The Street" TV brand is one of the longest-running U.S and International sponsored and Syndicated Nielsen Rated programs running today. Through its network of syndication, FMW programming reaches an estimated 540 million homes across US and international markets.
About Mango
Created using a special formulation featuring the same active ingredient as in Cialis™ (Tadalafil), each part of the Mango formulation plays a critical role in helping men achieve optimum performance. We believe the key to our success lies in our unique blend of ingredients, which are used in U.S. Food and Drug Administration (“FDA”) approved drugs. Mango contains a combination of Tadalafil, Oxytocin, and L-Arginine that have been traditionally used to treat sexual dysfunction.
Mango is a prescription medication that must be approved by a physician. After an individual has completed an online tele-health visit, our network of medical providers will review and approve a prescription if medically appropriate. Mango is a rapidly dissolved tablet (RDT) that is absorbed orally. For best results, we advise taking Mango at least 15 minutes before engaging in sexual activity. Tadalafil, one of the main ingredients in Mango, typically has effects that last up to 36 hours.
About Mangoceuticals
Mangoceuticals, Inc. is a company focused on developing, marketing, and selling a variety of men's health and wellness products and services via a secure telemedicine platform. To date, the Company has identified men's wellness telemedicine services and products as a growing sector and especially related to the area of erectile dysfunction (ED). The Company has developed a new brand of ED product under the brand name "Mango" (think: "Man, Go!"
.
For more information, please visit www.MangoRx.com.
July 12 2023 - 10:00AM
GlobeNewswire Inc.
Alert
Share On Facebook
Mangoceuticals, Inc. (NASDAQ:MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing and selling a variety of men’s health and wellness products via a secure telemedicine platform, including its uniquely formulated erectile dysfunction (ED) drug branded “Mango,” is pleased to announce air dates for the first episode of a multi-part TV series on FMW Media’s “New To The Street” business TV show featuring an in-depth interview with Mangoceuticals, Inc.’s CEO, Jacob Cohen.
The interview was filmed at the Nasdaq MarketSite Studio and will air on Fox Business Network, Bloomberg TV (as a sponsored program), and Newsmax TV (through its syndicated and sponsored networks) as follows:
July 22 at 3:30 p.m. ET on Newsmax TV
July 24 at 10:30 p.m. PT on Fox Business
August 5 at 6 p.m. ET on Bloomberg TV
Jane King, the host of New To The Street, sat down with Mr. Cohen to discuss Mangoceuticals’ vision, including how the Company identified its market opportunity and how it plans to execute its business plan in strategic planning terms.
In the interview, Mr. Cohen began by noting that the rise of direct-to-consumer telemedicine as an emerging pathway has attracted tremendous interest and the formation of many new businesses focused on selling health and wellness products through expanding telemedicine platforms.
But that the current product offerings amongst the competition in the market lacked innovation. MangoRx is predicated, in part, on stepping into that equation and introducing something capable of capitalizing on the emergence of direct-to-consumer telemedicine platforms while simultaneously disrupting the Men’s Health and Wellness marketplace. He points out that the Company’s first ED product represents an innovation in both formulation and in its sublingual delivery mechanism. He highlights the Company’s innovative formulation and its approach to marketing in the interview as well.
In addition to containing a proven ED pharma compound, Mango contains other ingredients that promote blood flow and intimacy. But it also offers a more efficient delivery mechanism through rapidly dissolved tablets (RDT) absorbed orally.
Mr. Cohen also discusses the Company’s unique marketing concept involving a high degree of overlap between its consumers and its investors, tying together investor relations and product marketing, which promotes additional ROI gains on capital invested in marketing efforts.
The interview expands to cover the Company’s vision for future expansion into other areas of Men’s Health and Wellness, including areas like hair loss, weight loss, mood, anti-aging, and even hormonal replacement therapies. Cohen concludes by pointing to the Company’s overall mission: to promote men’s performance in all areas and aspects of life.
FMW Media’s "New To The Street" TV brand is one of the longest-running U.S and International sponsored and Syndicated Nielsen Rated programs running today. Through its network of syndication, FMW programming reaches an estimated 540 million homes across US and international markets.
About Mango
Created using a special formulation featuring the same active ingredient as in Cialis™ (Tadalafil), each part of the Mango formulation plays a critical role in helping men achieve optimum performance. We believe the key to our success lies in our unique blend of ingredients, which are used in U.S. Food and Drug Administration (“FDA”) approved drugs. Mango contains a combination of Tadalafil, Oxytocin, and L-Arginine that have been traditionally used to treat sexual dysfunction.
Mango is a prescription medication that must be approved by a physician. After an individual has completed an online tele-health visit, our network of medical providers will review and approve a prescription if medically appropriate. Mango is a rapidly dissolved tablet (RDT) that is absorbed orally. For best results, we advise taking Mango at least 15 minutes before engaging in sexual activity. Tadalafil, one of the main ingredients in Mango, typically has effects that last up to 36 hours.
About Mangoceuticals
Mangoceuticals, Inc. is a company focused on developing, marketing, and selling a variety of men's health and wellness products and services via a secure telemedicine platform. To date, the Company has identified men's wellness telemedicine services and products as a growing sector and especially related to the area of erectile dysfunction (ED). The Company has developed a new brand of ED product under the brand name "Mango" (think: "Man, Go!"
. For more information, please visit www.MangoRx.com.
(0)
(0)
What I post is my opinion. Do your own DD. Make your own investment decision. Links, images, & retweets are not endorsements.
1️⃣I do not provide personal investment advice and I am not a qualified licensed investment advisor. I am an amateur investor.
2️⃣All information found here, including any ideas, opinions, views, predictions, forecasts, commentaries, suggestions, or stock picks, expressed or implied herein, are for informational, entertainment or educational purposes only and should not be construed as personal investment advice. While the information provided is believed to be accurate, it may include errors or inaccuracies.
3️⃣I will not and cannot be held liable for any actions you take as a result of anything you read here.
4️⃣Conduct your own due diligence, or consult a licensed financial advisor or broker before making any and all investment decisions. Any investments, trades, speculations, or decisions made on the basis of any information found on this site, expressed or implied herein, are committed at your own risk, financial or otherwise.
1️⃣I do not provide personal investment advice and I am not a qualified licensed investment advisor. I am an amateur investor.
2️⃣All information found here, including any ideas, opinions, views, predictions, forecasts, commentaries, suggestions, or stock picks, expressed or implied herein, are for informational, entertainment or educational purposes only and should not be construed as personal investment advice. While the information provided is believed to be accurate, it may include errors or inaccuracies.
3️⃣I will not and cannot be held liable for any actions you take as a result of anything you read here.
4️⃣Conduct your own due diligence, or consult a licensed financial advisor or broker before making any and all investment decisions. Any investments, trades, speculations, or decisions made on the basis of any information found on this site, expressed or implied herein, are committed at your own risk, financial or otherwise.
Scroll down for more posts ▼